The National Research Development Corporation (NRDC), under the Ministry of Science & Technology, and Dabur India have entered into licence agreements for commercialisation of Ayush-64, an ayurvedic formulation for treatment of Malaria, and Ayush-82, an ayurvedic formulation for management of diabetes. Both the formulations have been developed by Central Council for Research in Ayurvedic Sciences, an autonomous body, and the Ministry of AYUSH, an official release said.
The licence agreements were signed by H Purushotham on behalf of NRDCJ and LN Sastry, Head, Healthcare Research, on behalf of Dabur India, it added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.